Owners, management and financials
CVR: 39859211
Previous names: PrOxi Biotech IVS, PrOxi Biotech ApS
DKK -430,820
Gross profit
Net result: DKK -1,688,504
Aminzadeh Holding ApS (33,33-49,99%), Dr RJ Holding ApS (33,33-49,99%)
1 more
CVR · view owners
Rene Jørgensen, Aria Aminzadeh
Board: Sten Verland (chair) and 4 members
CVR · view management
Active
Founded 13 September 2018
CVR · view overview
6 employees
CVR · 2026
Name registered: Proxi Biotech ApS
CVR · 22/01/2025
View the full event history
Proxi Biotech ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PrOxi Biotech ApS and PrOxi Biotech IVS. The management consists of Rene Jørgensen and Aria Aminzadeh. The board consists of Sten Verland (chair), Aria Aminzadeh, Paul Jefferson Hargreaves and Per Bo Pedersen Fischer. The company is owned by Aminzadeh Holding ApS, Dr RJ Holding ApS and Century House Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK -430,820 and a net result of DKK -1,688,504 compared with DKK 426,762 the year before. Equity in the 2025 report amounted to DKK -1,712,625.
Selskabets formål er at udøve forskning og eksperimentel udvikling indenfor bioteknologi
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -431 t. | -1.7 mio. | 3 mio. | -1.7 mio. | 2 | |
| 202401/01/2024 – 31/12/2024 | 984 t. | 427 t. | 613 t. | 417 t. | 1 | |
| 202301/01/2023 – 31/12/2023 | 521 t. | 69 t. | 219 t. | -10 t. | 1 | |
| 202201/01/2022 – 31/12/2022 | 411 t. | -72 t. | 92 t. | -79 t. | 1 | |
| 202101/01/2021 – 31/12/2021 | 461 t. | 2 t. | 198 t. | -6 t. | 1 | |
| 202001/01/2020 – 31/12/2020 | 337 t. | 85 t. | 477 t. | -9 t. | 1 | |
| 201901/01/2019 – 31/12/2019 | 176 t. | -94 t. | 6 t. | -93 t. | 0 |
Compared to 1.038 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Proxi Biotech ApS is 39859211.
Proxi Biotech ApS is owned by Aminzadeh Holding ApS, Dr RJ Holding ApS and Century House Holding ApS.
The management of Proxi Biotech ApS consists of Rene Jørgensen and Aria Aminzadeh.
The board of Proxi Biotech ApS consists of Sten Verland, Aria Aminzadeh and Paul Jefferson Hargreaves, with Sten Verland as chair.
In 2025, Proxi Biotech ApS reported a gross profit of DKK -430,820.
Proxi Biotech ApS had 6 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Proxi Biotech ApS has published its annual report for 2025. Gross profit came to DKK -430,820, and the net result was DKK -1,688,504.
Contact info changed: new phone: 22552202, new email: [email protected], new website: www.proxibiotech.com (April 14, 2026).
As of December 19, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Proxi Biotech ApS.
As of December 19, 2025, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Proxi Biotech ApS.
As of November 10, 2025, Per Bo Pedersen Fischer has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Rene Jørgensen has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Sten Verland has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Aria Aminzadeh has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Paul Jefferson Hargreaves has joined the board of directors of Proxi Biotech ApS.
Proxi Biotech ApS has published its annual report for 2024. Gross profit came to DKK 983,921, and the net result was DKK 426,762.
As of April 9, 2025, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Proxi Biotech ApS.
As of April 9, 2025, JS Revision, Godkendt Revisionsaktieselskab has stepped down as auditor of Proxi Biotech ApS.
On January 22, 2025, the company changed its name from PrOxi Biotech ApS to Proxi Biotech ApS.
As of January 22, 2025, Dr RJ Holding ApS is registered as an owner of Proxi Biotech ApS with an ownership share of 33%.
As of January 22, 2025, Century House Holding ApS is registered as an owner of Proxi Biotech ApS.
As of January 7, 2025, Aminzadeh Holding ApS is registered as an owner of Proxi Biotech ApS with an ownership share of 33%.
Proxi Biotech ApS has published its annual report for 2023. Gross profit came to DKK 520,824, and the net result was DKK 68,661.
Proxi Biotech ApS has published its annual report for 2022. Gross profit came to DKK 411,123, and the net result was DKK -72,371.
Proxi Biotech ApS has published its annual report for 2021. Gross profit came to DKK 460,613, and the net result was DKK 2,349.
Proxi Biotech ApS has published its annual report for 2020. Gross profit came to DKK 336,912, and the net result was DKK 84,946.
As of November 29, 2020, Kasper Gubba Ørtenblad has stepped down as director of Proxi Biotech ApS.
As of June 10, 2020, Rene Jørgensen is registered as adm. dir. of Proxi Biotech ApS.
As of June 10, 2020, Kasper Gubba Ørtenblad is registered as director of Proxi Biotech ApS.
As of June 9, 2020, Rene Jørgensen has stepped down as director of Proxi Biotech ApS.
As of June 9, 2020, Kasper Gubba Ørtenblad has stepped down as adm. dir. of Proxi Biotech ApS.
Proxi Biotech ApS has published its annual report for 2019. Gross profit came to DKK 176,379, and the net result was DKK -93,581.
As of May 6, 2020, Rene Jørgensen is registered as director of Proxi Biotech ApS.
As of May 6, 2020, Aria Aminzadeh is registered as director of Proxi Biotech ApS.
As of April 15, 2020, JS Revision, Godkendt Revisionsaktieselskab has been appointed auditor of Proxi Biotech ApS.
As of April 15, 2020, Revisionshuset Tal & Tanker Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Proxi Biotech ApS.
As of November 10, 2019, Revisionshuset Tal & Tanker Statsautoriseret Revisionspartnerselskab has been appointed auditor of Proxi Biotech ApS.
On November 10, 2019, the company changed its name from PrOxi Biotech IVS to PrOxi Biotech ApS.
Proxi Biotech ApS has published its interim report for the period September 13, 2018 to December 31, 2018.
As of September 13, 2018, Kasper Gubba Ørtenblad is registered as adm. dir. of Proxi Biotech ApS.
Proxi Biotech ApS was founded on September 13, 2018.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 45950263
CVR 44828596
CVR 40633979
CVR 31888263
CVR 35249389
